Advances in 3D Printing of Biopharmaceuticals
Modern technology has enabled the development of novel dosage forms for targeted therapy. However, the fabrication of novel dosage forms at industrial scale is limited and the industry still runs on conventional drug delivery systems, especially modified tablets. The introduction of 3D printing technology in the pharmaceutical industry has opened new horizons in the research and development of printed materials and devices. The main benefits of 3D printing technology lie in the production of small batches of medicines, each with tailored dosages, shapes, sizes, and release characteristics.
Industrial and academic researchers have recently examined the use of 3D printing technologies to overcome the limitations associated with conventional manufacturing processes. These technologies involved fabrication of three-dimensional structures through additive joining of materials in a layer-by-layer manner. The introduction of 3D printing technology in the pharmaceutical industry has opened new horizons in the research and development of printed materials and devices. The main benefits of 3D printing technology lie in the production of small batches of medicines, each with tailored dosages, shapes, sizes, and release characteristics. The manufacture of medicines in this way may finally lead to the concept of personalized medicines becoming a reality.
By way of followup, this week’s available deck is titled “Advances in 3D printing of biopharmaceuticals” from Joseph Della Rocca at Merck. Joe was a past speaker at our Global Drug Bioavailability Enhancement Summit. This presentation overviews 3D printing technologies in biotechnology, 3D printed dosage forms for on-site formulation and 3D printing technology at Merck as a tool to guide formulation development. It additionally examines 3DP capsules for regional absorption studies, 3DP controlled release capsules, development of 3DP filaments for clinical use and conversion of the 3DP capsule to clinically relevant materials. To view this presentation and other novel delivery and bioavailability enhancement approaches, click below.
Our goal is to help you improve the performance of your drug products. The next generation of peptide drug and therapeutic delivery is here. Are you looking to improve the performance of your peptide drug products?
Hear from over 30 peptide drug commercialization experts and connect with 100’s of senior drug product development experts from pharma, biotech and speciality drug development organizations. 2021’s Summit will examine various peptide discovery and synthesis techniques and synthesized and modified peptides. Learn novel strategies for improving peptide stability and half-life, along with novel routes of administration, and walk away with over 2 years of new peptide commercialization strategies in just 2 days!
Register to attend today and walk away with game-changing development strategies which could decrease time-to-market and save you millions. Don’t miss your chance to attend 2021’s one-of-a-kind Summit at the lowest available registration rate!
Want multiple free peptide drug development approaches?
The past 12 months have only highlighted the need for effective, affordable drug products and therapeutics, developed in a safe, timely fashion. Still one of healthcare’s biggest challenges. Our goal is to be a valuable resource to you and your team members in order to help you improve the performance and development of your future drug products.
Access over 115 unique drug product development approaches designed to help you and your team learn, network and stay up-to-date with advances in industrial drug product development, remotely and conveniently.
This is your free one stop resource for innovative drug development digital content. Stay ahead of the curve and gain access to 3 year’s worth of leading industry presentations and case studies from the previous Controlled & Modified Drug Release Summits, Peptide Drug Design & Delivery Summits & Global Drug Bioavailability Enhancement Summits. Access them all instantly below.